Skip to main content
. 2020 Jul 15;16(7):1091–1098. doi: 10.5664/jcsm.8432

Table 1.

Clinical characteristics of sleep cohort with lung cancer.

Total (n = 23) Non-OSA (n = 2)
Age, y 62.4 ± 11.6 67.5 ± 10.6
Sex, male (%) 22 (95) 2 (100)
BMI 26.6 ± 4.8 27.5 ± .7
Smoker, PKY 37.4 ± 37.2 20 ± 14.0
ESS score 11.6 ± 4.9 13.5 ± 2.1
Polysomnography
 AHI 41.3 ± 27.0 3.0 ± .0
 ODI 31.6 ± 25.0 4.0 ± 1.4
 Lowest SpO2 80.7 ± 8.8 84.0 ± 2.8
Tsat90% 17.1 ± 26.7 4.0 ± 2.5
Tsat90 mins 32.5 ± 63.8 8.5 ± 6.3
OSA severity (%)
 Mild 2 (9) 0 (0)
 Moderate 4 (17) 0 (0)
 Severe 15 (65) 0 (0)
ECOG status .7 ± .7 .5 ± .7
Cancer stage (%)
 Stage I 6 (26) 0 (0)
 Stage II 1 (4) 1 (50)
 Stage III 4 (17) 1 (50)
 Stage IV 12 (53) 0 (0)
Pathology (%)
 Adenocarcinoma 14 (61) 1 (50)
 Squamous cell 6 (26) 1 (50)
 Other 3 (13) 0 (0)
3-y mortality (%) 65% 0%
5-y mortality (%) 83% 50%

Data presented as mean ± SD or number (percentage). BMI = body mass index, ECOG = Eastern Cooperative Oncology Group, ESS = Epworth Sleepiness Scale, ODI = oxygen desaturation index, PKY = packs per year, SpO2 = oxygen saturation, Tsat90% = percentage of sleep time with oxygen saturation < 90%, Tsat90 mins = total sleep time (minutes) with oxygen saturation < 90%.